Cargando…
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic()
Autores principales: | Marijnen, C.A.M., Peters, F.P., Rödel, C., Bujko, K., Haustermans, K., Fokas, E., Glynne-Jones, R., Valentini, V., Spindler, K-L.G., Guren, M.G., Maingon, Philippe, Calvo, F.A., Pares, O., Glimelius, B., Sebag-Montefiore, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194592/ https://www.ncbi.nlm.nih.gov/pubmed/32342861 http://dx.doi.org/10.1016/j.radonc.2020.03.039 |
Ejemplares similares
-
Patient-reported outcomes in PROSPECT trial (Alliance N1048) – FOLFOX is not a panacea
por: O'Cathail, Sean M., et al.
Publicado: (2023) -
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study
por: Glynne-Jones, R, et al.
Publicado: (2007) -
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study
por: Sebag-Montefiore, D, et al.
Publicado: (2005) -
Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery
por: Osong, Biche, et al.
Publicado: (2022) -
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)
por: Northover, J, et al.
Publicado: (2010)